TCR(2) Therapeutics Presents Positive Solid Tumor Data for its Novel TRuC™ Engineered T Cell Therapies at the … – PR Newswire (press release)
|
TCR(2) Therapeutics Presents Positive Solid Tumor Data for its Novel TRuC™ Engineered T Cell Therapies at the …
PR Newswire (press release) CAMBRIDGE, Mass., June 13, 2017 /PRNewswire/ — TCR2 Therapeutics Inc. announced data today on two of its TRuC™ programs that showed superior persistence and anti-tumor activity of the company's TRuC™-T cells compared to CAR–T cells in … |
